SY17-4 Optimal treatment strategy for locally advanced nasopharyngeal cancer from the perspectives of Asian endemic region

Abstract

In locoregionally advanced NPC, the addition of platinum-based induction chemotherapy and cisplatin concurrent chemotherapy to radiotherapy (RT) have been consistently associated with survival benefits. Trials of adjuvant chemotherapy have yielded mixed results. The role of plasma EBV DNA in guiding the choice of induction and adjuvant chemotherapy continues to be an area of active investigation. A positive randomized study of metronomic adjuvant chemotherapy using capecitabine has offered another alternative approach for future investigations.